USANA Health Sciences Inc (USNA)
Return on total capital
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 102,715 | 98,793 | 101,475 | 104,026 | 108,813 | 117,643 | 134,755 | 159,677 | 170,699 | 192,458 | 197,742 | 183,612 | 178,455 | 170,856 | 161,114 | 153,440 | 150,562 | 154,210 | 164,834 | 183,851 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 497,202 | 470,394 | 468,824 | 455,354 | 434,472 | 411,099 | 403,681 | 389,946 | 395,124 | 399,079 | 418,623 | 402,777 | 441,650 | 389,117 | 349,076 | 317,608 | 351,712 | 314,286 | 384,156 | 391,217 |
| Return on total capital | 20.66% | 21.00% | 21.64% | 22.85% | 25.04% | 28.62% | 33.38% | 40.95% | 43.20% | 48.23% | 47.24% | 45.59% | 40.41% | 43.91% | 46.15% | 48.31% | 42.81% | 49.07% | 42.91% | 46.99% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $102,715K ÷ ($—K + $497,202K)
= 20.66%
The return on total capital for USANA Health Sciences Inc has demonstrated a generally positive trend over the periods indicated. The ratio has ranged from 20.66% to 49.07% over the past few years, reflecting the company's ability to generate profits relative to the total capital employed in its operations.
The return on total capital peaked at 49.07% in the third quarter of 2019 and has shown some fluctuations since then. Despite the fluctuations, the ratio has generally remained above 40%, indicating that the company has been efficiently utilizing its capital to generate returns for its investors.
Overall, the trend suggests that USANA Health Sciences Inc has been effectively managing its capital allocation and operational performance to generate solid returns for its shareholders. It is important for investors and stakeholders to continue monitoring this ratio to assess the company's ability to sustain and improve its performance over time.